Skip to main content

Table 1 Clinical data of patients with solitary lung metastasis of prostatic cancer

From: Solitary pulmonary metastasis from prostate cancer with neuroendocrine differentiation: a case report and review of relevant cases from the literature

Author

Year

Age (years)

Initial characteristic

Initial treatment

Adjuvant/salvage treatment

Lung meta. characteristics

Solitary lung meta. treatment

Pathology

Outcome

Present case

 

50

PSA 61.7, cT4, GS4 + 5

Neoadjuvant endocrine therapy radiation therapy

None

Left S5, 3 cm

Lobectomy and mediastinal LND

PSAP (+), chromogranin (+), synaptophysin (+), CD56/CD57 (+), surfactant apoprotein (−), CK20/CK7 (−), mediastinal LN meta

Died 2.5 years after metastases detected

Pepe et al. [6]

2012

75

PSA 8.3, pT3a, GS4 + 3, mixed acinar and ductal prostate ca

Radical prostatectomy

None

Left S6, 2 cm

Metastatectomy

PSAP (+), TTF-1 (−)

Undetectable

Sakai et al. [7]

2010

74

Unknown

Neoadjuvant endocrine therapy radiation therapy

Neoadjuvant endocrine therapy

Left S8, 2.2 cm

Wedge resection

PSAP (+), P504 (+), pleural dissemination

Undetectable

Goto et al. [9]

2010

73

PSA 14.37, GS4 + 5, pT4, P/D adenoca with sarcomatoid carcinoma component

Nneoadjuvant endocrine therapy. pelvic evisceration

None

Left S3, 2 cm

Wedge resection

PSAP (−), cytokeratin A/E1/3 (+), cytokeratin7 (−), cytokeratin20 (−), vimentin (−), undifferentiated carcinoma

Undetectable

Boyer et al. [13]

2009

65

PSA 3, GS3 + 3, pT2

Radical prostatectomy

None

Left upper lobe, 2.8 cm

Surgical resection

Unknown

Undetectable

Khandani et al. [12]

2009

78

Prostate cancer only

Radiation therapy

None

Left S10, 5 cm

Lobectomy and mediastinal LND

PSAP (−)

Undetectable

Pruthi et al. [10]

2007

72

PSA 4.1, GS3 + 3, pT2b

radical prostatectomy

salvage radiation therapy

left S8, 2 cm

endocrine therapy and surgical resection

PSAP (+), GS 8, subcarinal LN meta

3-year disease free follow up

Chao et al. [4]

2004

68

PSA 6.7, GS4 + 5, pT2a

Radical prostatectomy

None

Left lower lobe, 1.2 cm

Wedge resection

PSAP (+), W-M/D adenoca

12-year disease free follow up

Hofland et al. [8]

2000

49

GS 4 + 5, pT3c, P/D adenoca

Radical prostatectomy

Salvage radiation therapy, endocrine therapy and orchiectomy

Left lower lobe only

Lobectomy

PSAP (+), P/D adenoca

Metastases, undetectable

Smith et al. [5]

1999

70

GS4 + 5, pT2

Radical prostatectomy

None

Right S7, 2 cm

Surgical resection

PSAP (+), P/D adenoca

Undetectable

Rockey et al. [14]

1990

83

Low grade prostate cancer only

Radiation therapy

None

Left lower lobe only

Orchiectomy

PSAP (+), meta. Only

Undetectable

Fabozzi et al. [3]

1995

11 cases: details unknown

Varkarakis et al. [11]

1974

One case, details unknown

  1. ‘+’, Positive; PSA: prostate-specific antigen; NEC: neuroendocrine carcinoma; NET: neuroendocrine tumor; NENs: neuroendocrine neoplasms; GS: Gleason score; PSAP: prostate-specific antigen phosphatase; CD56/57: Neural cell adhesion molecule/Leu 7; adenoca: adenocarcinoma; LND: lymph node dissection.